Search - tctmd.com

Displaying 201 - 220 of 337

Sort: Relevancy | Date

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

Presentation

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

Presenter: H. Shiomi

March 19, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

Presentation

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Presenter: Alfredo E. Rodriguez

December 30, 2013

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

Presentation

ST with Second-generation DES vs. BMS: Network Meta-analysis of Primary PCI Trials in STEMI

Presenter: 183206|Femi Philip

December 08, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

DCB and BMS Interaction: A Critical Look at the Data

Presenter: Francesco Liistro

October 31, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

News Daily News

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Yael L. Maxwell

October 25, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

Advertisement

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

ST with Second-generation DES vs. BMS: Network Meta-analysis of Primary PCI Trials in STEMI

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

DCB and BMS Interaction: A Critical Look at the Data

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

Innovative Stent-Grafts Safe, Feasible for High-Risk Complex Aortic Aneurysms

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content